Thus, we hypothesized that different phenotypes of patients with Type 2 diabetes can be determined in terms of insulin-mediated glucose uptake patterns in brain regions by using [18F]FDG-PET imaging in combination with a hyperinsulinaemic euglycaemic clamp (HEC). This evidence concerns the gene INS and type 2 diabetes mellitus.